Clinical Trial Update: Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism

View source ↗

Summary

A post-registration trial of a non-immunogenic staphylokinase for massive pulmonary embolism is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Non-immunogenic staphylokinase (staphylokinase)

Snippet

Sponsor: Supergene, LLC | Conditions: Pulmonary Embolism Acute Massive | Status: RECRUITING